Eczema: discoid (syn. nummular) eczema

LAST UPDATED: May 28, 2022

Patient Information Leaflet
Link: Eczema - discoid eczema

https://www.pcds.org.uk/patient-info-leaflets/eczema-discoid-eczema

Introduction

The term discoid eczema comes from its characteristic round or oval 'disc-shaped' patches. For the same reason it is sometimes also called nummular eczema - nummular meaning coin-shaped. The cause of discoid eczema is unknown.

This chapter is set out as follows:


History

  • Age - most commonly presents in middle-aged patients, but can affect any age group 
  • Often very itchy
  • Can be associated with excessive bathing or swimming

Clinical findings

Distribution

  • Can occur anywhere although the limbs predominate

Morphology

  • Discrete round / oval patches
  • Differs from psoriasis in that lesions tend to be a lighter red, the border fades gradually at the periphery and they may have an exudate / crust as opposed to scale 

Clinical Images

Please refer to notes on image rights at bottom of the page with regards to individual image ownership.


Management

  • Refer to the top right of the page for a patient information leaflet available through a QR code or printable PDF

  • Acute treatment - short-term use of a potent topical steroid, eg 0.1% betamethasone cream OD until things settle 
  • Long-term treatment - regular use of a topical emollient (prescribe 500 g), at least twice a day, with the same topical steroid reintroduced for a flare. The more emollient used, the less the skin will flare, limiting the use of topical steroids (although it is safe for adults to use approximately 100 g of a potent topical steroid per month if required, bearing in mind applications over areas of thin skin such as the face and shins should be kept to a minimum)  
  • For more detailed information on management refer to the related chapter Atopic Eczema, as the management principles are similar 

Disclaimer - the author PCDS cannot accept responsibility for any misleading or incorrect statements, and the management of individual patients remains the direct responsibility of the individual doctor. We do however hope that visitors to this site can contact us regarding comments that are considered misleading or incorrect so that we can continue to improve the site.

Image Rights - The PCDS would like to thank Dermatoweb, DermQuest (Galderma), and others who have contributed images. All named individuals and organisations maintain copyright for the relevant images.

Quick Links

The following pharmaceutical companies have had no involvement in the content of this website or in our conference programmes

Almirall
Galderma
Glenmark
Johnson & Johnson
La Roche-Posay
LEO Pharma
Pierre Fabre
Schuco